Patrick Hurban, Ph.D. | January 20, 2016

Precision Medicine: Applying Genomics Outside of Oncology

Part two
Genomic technologies have been widely adopted within oncology, according to Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions. In the second video from a three-part series, Hurban discusses the use of genomics for non-oncology trials and many other therapeutic areas as well. Watch to learn more.

Related Services:
Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More